Literature DB >> 27012388

Management of Atypical and Anaplastic Meningiomas.

Simon Buttrick1, Ashish H Shah1, Ricardo J Komotar1, Michael E Ivan2.   

Abstract

Meningiomas are the most prevalent primary tumor of central nervous system origin and, although most neoplasms are benign, a small proportion exemplifies an aggressive profile characterized by high recurrence rates, pleomorphic histology, and overall resistance to standard treatment. Standard initial therapy for malignant meningiomas includes maximal safe surgical resection followed by focal radiation in certain cases. The role for chemotherapy during recurrence of these aggressive meningiomas is less clear. Prognosis is poor and recurrence of malignant meningiomas is high. This article provides an overview of atypical and anaplastic malignant meningiomas, their treatment, and ongoing research for more effective treatments.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaplastic meningioma; Atypical meningioma; Chemotherapy; Malignant meningioma; Radiation therapy; Recurrence

Mesh:

Year:  2016        PMID: 27012388     DOI: 10.1016/j.nec.2015.11.003

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  13 in total

1.  Atypical and anaplastic meningioma: outcomes in a population based study.

Authors:  T Garzon-Muvdi; W Yang; M Lim; H Brem; J Huang
Journal:  J Neurooncol       Date:  2017-04-20       Impact factor: 4.130

2.  Pyrosequencing Analysis of MGMT Promoter Methylation in Meningioma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Henning Leske; Pitt Niehusmann; Lene E Johannessen; Julie Staurseth; Nina Øino; Torstein R Meling; Sverre Heim; Francesca Micci; Petter Brandal
Journal:  Cancer Genomics Proteomics       Date:  2018 Sep-Oct       Impact factor: 4.069

3.  A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma.

Authors:  Fares Nigim; Juri Kiyokawa; Alessandra Gurtner; Yoichiro Kawamura; Lingyang Hua; Ekkehard M Kasper; Priscilla K Brastianos; Daniel P Cahill; Samuel D Rabkin; Robert L Martuza; W Shawn Carbonell; Hiroaki Wakimoto
Journal:  Target Oncol       Date:  2019-08       Impact factor: 4.493

4.  Fertility treatment is associated with multiple meningiomas and younger age at diagnosis.

Authors:  Maryam N Shahin; Stephen T Magill; Cecilia L Dalle Ore; Jennifer A Viner; Pamela N Peters; David A Solomon; Michael W McDermott
Journal:  J Neurooncol       Date:  2019-03-13       Impact factor: 4.130

Review 5.  Current experimental therapies for atypical and malignant meningiomas.

Authors:  Andres M Corona; Long Di; Ashish H Shah; Raphael Crespo; Daniel G Eichberg; Victor M Lu; Evan M Luther; Ricardo J Komotar; Michael E Ivan
Journal:  J Neurooncol       Date:  2021-05-05       Impact factor: 4.130

6.  [Comparative analysis of Grade I vs Grade II intracranial Meningiomas in a retrospective series of 63 patients].

Authors:  Federico Coppola; Juan Iaconis Campbell; Juan Manuel Herrero; Emilio Volpe; Tito Cersosimo
Journal:  Surg Neurol Int       Date:  2017-10-24

7.  The Efficacy and Safety of Carbon Ion Radiotherapy for Meningiomas: A Systematic Review and Meta-Analysis.

Authors:  Jie-Yun Li; Jing-Wen Li; Yuan-Chang Jin; Mei-Xuan Li; Li-Ping Guo; Zhi-Tong Bing; Qiu-Ning Zhang; Fei Bai; Xiao-Hu Wang; Xiu-Xia Li; Ke-Hu Yang
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

8.  Chrysophanol inhibits the osteoglycin/mTOR and activats NF2 signaling pathways to reduce viability and proliferation of malignant meningioma cells.

Authors:  Jiapeng Wang; Peng Lv
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

9.  Bioactivity and safety of B7-H3-targeted chimeric antigen receptor T cells against anaplastic meningioma.

Authors:  Xin Tang; Fujun Liu; Zhiyong Liu; Yi Cao; Zongliang Zhang; Yuelong Wang; Jianhan Huang; Shuangming Fan; Shasha Zhao; Yaxin Chen; Gaowei Li; Shan Wang; Meijun Zheng; Yating Hu; Hongjian Li; Caiying Jiang; Meijia Yang; Hui Yang; JianGuo Xu; Gang Guo; Aiping Tong; Liangxue Zhou
Journal:  Clin Transl Immunology       Date:  2020-06-12

10.  An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures.

Authors:  Grace Collord; Patrick Tarpey; Natalja Kurbatova; Inigo Martincorena; Sebastian Moran; Manuel Castro; Tibor Nagy; Graham Bignell; Francesco Maura; Matthew D Young; Jorge Berna; Jose M C Tubio; Chris E McMurran; Adam M H Young; Mathijs Sanders; Imran Noorani; Stephen J Price; Colin Watts; Elke Leipnitz; Matthias Kirsch; Gabriele Schackert; Danita Pearson; Abel Devadass; Zvi Ram; V Peter Collins; Kieren Allinson; Michael D Jenkinson; Rasheed Zakaria; Khaja Syed; C Oliver Hanemann; Jemma Dunn; Michael W McDermott; Ramez W Kirollos; George S Vassiliou; Manel Esteller; Sam Behjati; Alvis Brazma; Thomas Santarius; Ultan McDermott
Journal:  Sci Rep       Date:  2018-09-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.